In patients with a right-sided tumor and wild-type RAS, median OS was 18.62, 19.31, and 24.62 months with anti-VEGF, anti-EGFR, and chemotherapy alone, respectively (p = 0.201). This evidence concerns the gene EGFR and neoplasm.